Polyethylene Glycol
Composition
This formulation contain Polyethylene Glycol (PEG) pharmaceutical ingrediant.
Indications
It is indicated for the treatment of constipation, bowel preparation for colonoscopy, and for the management of hepatic encephalopathy.
Side effects
Common side effects include bloating, abdominal cramping, flatulence, and nausea
Precautions
Use with caution in patients with impaired renal function or congestive heart failure.
Contraindications
Contraindicated in patients with known hypersensitivity to PEG or any component of the formulation.
Dosage and administration
As directed by healthcare provider.
Countries
Worldwide
Available Forms
Oral powder for solutions
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai